After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Cidara Therapeutics Inc is $607.51M. A total of 3.47 million shares were traded on the day, compared to an average of 275.47K shares.
In the most recent transaction, Mineo Chrysa bought 2,270 shares of CDTX for 21.71 per share on Jun 02 ’25. After the transaction, the Director now owns 2,270 company shares. In a previous transaction on Jun 03 ’25, Mineo Chrysa bought 1,050 shares at 23.44 per share. CDTX shares that Director owns now total 3,320.
Among the insiders who sold shares, Ward Shane disposed of 1,664 shares on Mar 11 ’25 at a per-share price of $21.96. This resulted in the COO & CLO holding 14,674 shares of CDTX after the transaction. In another insider transaction, Tari Leslie sold 1,773 shares at $21.96 per share on Mar 11 ’25. Company shares held by the CHIEF SCIENTIFIC OFFICER now total 16,215.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CDTX has a high of $45.39 and a low of $10.14.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CDTX’s latest balance sheet shows that the firm has $59.68M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $34.02M in liabilities at the time. Its Book Value Per Share was $11.60, while its Total Shareholder’s Equity was $21.57M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDTX is Buy with a score of 4.71.
